B. M. Peskar

5.1k total citations · 1 hit paper
95 papers, 4.2k citations indexed

About

B. M. Peskar is a scholar working on Pharmacology, Surgery and Physiology. According to data from OpenAlex, B. M. Peskar has authored 95 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmacology, 41 papers in Surgery and 23 papers in Physiology. Recurrent topics in B. M. Peskar's work include Inflammatory mediators and NSAID effects (50 papers), Helicobacter pylori-related gastroenterology studies (33 papers) and Eicosanoids and Hypertension Pharmacology (19 papers). B. M. Peskar is often cited by papers focused on Inflammatory mediators and NSAID effects (50 papers), Helicobacter pylori-related gastroenterology studies (33 papers) and Eicosanoids and Hypertension Pharmacology (19 papers). B. M. Peskar collaborates with scholars based in Germany, Austria and United States. B. M. Peskar's co-authors include Bernhard A. Peskar, Michael Respondek, Andrzej S. Tarnawski, Nenad Maricic, Hongtao Wang, Ellis R. Levin, Michael K. Jones, I. James Sarfeh, Karlheinz Ehrlich and Britta Gretzer and has published in prestigious journals such as Nature Medicine, Gastroenterology and Gut.

In The Last Decade

B. M. Peskar

94 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing

1999 708 citations B. M. Peskar et al. profile →

Peers

Countries citing papers authored by B. M. Peskar

Since Specialization

Citations

This map shows the geographic impact of B. M. Peskar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. M. Peskar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. M. Peskar more than expected).

Fields of papers citing papers by B. M. Peskar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. M. Peskar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. M. Peskar. The network helps show where B. M. Peskar may publish in the future.

Co-authorship network of co-authors of B. M. Peskar

This figure shows the co-authorship network connecting the top 25 collaborators of B. M. Peskar. A scholar is included among the top collaborators of B. M. Peskar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. M. Peskar. B. M. Peskar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Lipoxygenases and the Lipoxin A<sub>4</sub>/Annexin 1 Receptor in Ischemia-Reperfusion-Induced Gastric Mucosal Damage in Rats 2009 ·Pharmacology ·B. M. Peskar, Karlheinz Ehrlich, Rufina Schuligoi, Bernhard A. Peskar	18
2	Role of Lipoxygenases and Lipoxin A<sub>4</sub>/Annexin-1 Receptor in Gastric Protection Induced by 20% Ethanol or Sodium Salicylate in Rats 2009 ·Pharmacology ·B. M. Peskar, Karlheinz Ehrlich, Rufina Schuligoi, Bernhard A. Peskar	8
3	Effekte von Diclofenac und selektiven Cyclooxygenase-(COX-)2-Inhibitoren auf die Prostaglandinfreisetzung aus entz�ndetem Bursa-subacromialis-Gewebe von Patienten mit Subakromialsyndrom in vitro 2004 ·Der Orthopäde ·(unknown), R. H. Wittenberg, (unknown), (unknown), Wolfgang E. Schmidt, B. M. Peskar, M. Wiese, (unknown), R. Willburger	1
4	Interaction of Cyclooxygenase Isoenzymes, Nitric Oxide, and Afferent Neurons in Gastric Mucosal Defense in Rats 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Karlheinz Ehrlich, (unknown), Michael Respondek, B. M. Peskar	27
5	Role of cyclooxygenase isoforms in gastric mucosal defence 2001 ·Journal of Physiology-Paris ·B. M. Peskar	74
6	Role of cyclooxygenase-2 in gastric mucosal defense 2001 ·Life Sciences ·B. M. Peskar, Nenad Maricic, Britta Gretzer, Rufina Schuligoi, Adrian Schmassmann	56
7	Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats 1998 ·British Journal of Pharmacology ·Adrian Schmassmann, B. M. Peskar, C Stettler, Peter Netzer, Thomas Stroff, Beatrice Flogerzi, F Halter	246
8	Selective cyclo‐oxygenase‐2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach 1998 ·British Journal of Pharmacology ·Britta Gretzer, Karlheinz Ehrlich, Nenad Maricic, Nils Lambrecht, Michael Respondek, B. M. Peskar	92
9	Interaction of 5-aminosalicylic acid with nitric oxide on rat aortic strips and human platelets 1995 ·European Journal of Pharmacology ·Dirk Pallapies, Bernhard A. Peskar, B. M. Peskar, (unknown), (unknown)	4
10	Mediation by CCK_B receptors of the CCK‐evoked hyperaemia in rat gastric mucosa 1995 ·British Journal of Pharmacology ·Ákos Heinemann, Milana Jocič, Ulrike Holzer‐Petsche, Gábor Pethö, B. M. Peskar, David C. Horwell, Peter Holzer	14
11	Role of eicosanoids, nitric oxide, and afferent neurons in antacid induced protection in the rat stomach. 1993 ·Gut ·Nils Lambrecht, M Trautmann, Roman Korolkiewicz, (unknown), B. M. Peskar	22
12	Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats 1993 ·Digestive Diseases and Sciences ·(unknown), Stefan Kluge, B. M. Peskar	118
13	Aspirin-like drugs, ethanol-induced rat gastric injury and mueosal eicosanoid release 1991 ·European Journal of Pharmacology ·M Trautmann, B. M. Peskar, Bernhard A. Peskar, (unknown), (unknown)	12
14	Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: Effect of non-steroidal anti-inflammatory drugs 1991 ·Inflammation Research ·B. M. Peskar, M Trautmann, Przemysław Nowak, Bernhard A. Peskar	32
15	Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo 1991 ·Prostaglandins ·B. M. Peskar, Stefan Kluge, Bernhard A. Peskar, (unknown), Kay Brune	43
16	Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition 1991 ·Cellular and Molecular Life Sciences ·Kay Brune, W Beck, Gerd Geißlinger, S. Menzel-Soglowek, B. M. Peskar, Bernhard A. Peskar	126
17	Afferent nerve-mediated protection against deep mucosal damage in the rat stomach 1990 ·Gastroenterology ·Peter Holzer, Maria Anna Pabst, Irmgard Th. Lippe, B. M. Peskar, Bernhard A. Peskar, Edward H. Livingston, Paul H. Guth	161
18	Lipoxygenase products of polyunsaturated fatty acid metabolism in the central nervous system: Biosynthesis and putative functions 1990 ·Pharmacological Research ·(unknown), B. M. Peskar	30
19	The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed 1989 ·Prostaglandins ·A. Dembińska-Kieć, Bernhard A. Peskar, Michael Müller, B. M. Peskar	20
20	Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma 1984 ·Prostaglandins Leukotrienes and Medicine ·(unknown), R. Voigtmann, Bernhard A. Peskar, B. M. Peskar, (unknown), (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact